Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD
肝脏 CPT1A 基因疗法可减少小鼠饮食引起的肝脂肪变性，并突出人类 NAFLD 的潜在脂质生物标志物
期刊:FASEB Journal
影响因子:4.4
doi:10.1096/fj.202000678R
Minéia Weber, Paula Mera, Josefina Casas, Javier Salvador, Amaia Rodríguez, Sergio Alonso, David Sebastián, M Carmen Soler-Vázquez, Carla Montironi, Sandra Recalde, Raquel Fucho, María Calderón-Domínguez, Joan Francesc Mir, Ramon Bartrons, Joan Carles Escola-Gil, David Sánchez-Infantes, Antonio Zorz
